Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04784429 · ClinicalTrials.gov registry record · NA

Assessing Outcomes With Microprocessor Knee Utilization in a K2 Population

A NA study of Lower Limb Amputation Above Knee (Injury) and Lower Limb Amputation Knee, sponsored by Otto Bock Healthcare Products.

Active
Registry status
NA
Development phase
107
Enrollment target
20
Study locations

NCT04784429: Active NA study of Lower Limb Amputation Above Knee (Injury) and Lower Limb Amputation Knee, sponsored by Otto Bock Healthcare Products.

NCT04784429 is a NA study of Lower Limb Amputation Above Knee (Injury) and Lower Limb Amputation Knee that is active but no longer recruiting, run by Otto Bock Healthcare Products. The registered enrollment target is 107 participants, above the 73-participant average among 6 other Lower Limb Amputation Above Knee (Injury) trials with a reported enrollment target (47% higher). The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04784429, a NA study of Lower Limb Amputation Above Knee (Injury) and Lower Limb Amputation Knee, is active but no longer recruiting, sponsored by Otto Bock Healthcare Products.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
107 participants
Enrollment target
20
Study locations

Study Summary

Two-phased randomized controlled trial comparing the impact of microprocessor controlled knee prostheses (MPK) with the impact of non-microprocessor controlled knee prostheses (NPMK) in patients with a transfemoral/knee disarticulation level amputation categorized as K2 ambulators.

Primary Outcome

This is a 14 item survey assessment originally developed with community-dwelling older adults which measures the degree to which respondents avoid activities due to their fear of falling. Responses are on a 5-point scale with 0 = completely disagree and 4 = completely agree. The total possible score is 56 points. A higher score indicates a greater activity limitation and participation restriction as a result of the fear of falling.

Interventions

  • DEVICE Kenevo or C-Leg 4
  • DEVICE Non microprocessor controlled knee (NMPK)

Study Locations (20)

Florida

  • Hanger Clinic - 1119 Professional Park Drive - Brandon
  • Hanger Clinic - 1400 Mason Ave. Suite 103 - Daytona Beach
  • Hanger Clinic - 12591 Creekside Lane - Fort Myers
  • Hanger Clinic - 221 W. Main Street - Inverness
  • Hanger Clinic - 308 East Oak Street - Kissimmee
  • Hanger Clinic - 6270 Naples Blvd, Bldg 1 - Naples
  • Hanger Clinic - 824 Creighton Road - Pensacola
  • Hanger Clinic - 200 Southpark Blvd, Suite 209 - Saint Augustine

California

  • Hanger Clinic - 4849 Lonetree Way, STE B - Antioch
  • Hanger Clinic - 1743 Creekside, Suite #110 - Folsom
  • Hanger Clinic - California - 1248 32nd St - Sacramento
  • Hanger Clinic - 23451 Madison St., Suite 200, Skypark Building 7 - Torrance
  • Hanger Clinic - 820 S Akers St, Ste 230 - Visalia
  • Hanger Clinic - 1215 Plumas Street, Suite 1000 - Yuba City

Arizona

  • Hanger Clinic - 3501 S Mercy Road - Gilbert
  • Hanger Clinic - 3816 N. 7th St. - Phoenix
  • Hanger Clinic - 4045 E Bell Rd - Phoenix
  • Hanger Clinic - 13925 Meeker Blvd, Suite 5 - Sun City West

Alabama

  • Hanger Clinic - 321 Westgate Pkwy - Dothan

Colorado

  • Hanger Clinic - St. Anthony Hospital - Medical Plaza 1, Suite 230, 11750 West 2nd Place - Lakewood

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 2021-06-11
Est. Completion 2026-12-31
Phase NA
Otto Bock Healthcare Products

5 total trials

What the registry record for NCT04784429 still lists

NCT04784429 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, above the 73-participant average among 6 other Lower Limb Amputation Above Knee (Injury) trials with a reported enrollment target (47% higher).

The record links to 3 conditions, with Lower Limb Amputation Above Knee (Injury) appearing as the primary indexed condition, and to 2 interventions - of which Kenevo or C-Leg 4 is the first listed.

NCT04784429 names 20 study sites across 5 states, led by Florida, California, Arizona.

Frequently Asked Questions

What is clinical trial NCT04784429 about?

NCT04784429 is a clinical study titled "Assessing Outcomes With Microprocessor Knee Utilization in a K2 Population". Two-phased randomized controlled trial comparing the impact of microprocessor controlled knee prostheses (MPK) with the impact of non-microprocessor controlled knee prostheses (NPMK) in patients with a transfemoral/knee disarticulation level amputation categorized as K2 ambulators.

What is the current status of trial NCT04784429?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 107 participants. The study started on 2021-06-11. Estimated completion is 2026-12-31.

What conditions does trial NCT04784429 study?

This clinical trial studies the following conditions: Lower Limb Amputation Above Knee (Injury), Lower Limb Amputation Knee, Congenital Amputation of Lower Limb.

What interventions are being tested in trial NCT04784429?

The interventions under investigation include: Kenevo or C-Leg 4 (DEVICE), Non microprocessor controlled knee (NMPK) (DEVICE).

Who is sponsoring clinical trial NCT04784429?

This trial is sponsored by Otto Bock Healthcare Products, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04784429 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lower Limb Amputation Above Knee (Injury)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05491668 · 107 participants

    Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI

  • NCT06041594 · 107 participants · NA

    Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

  • NCT06081426 · 107 participants · NA

    Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)

  • NCT06527599 · 107 participants · NA

    Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04784429, the US trial registry maintained by the National Library of Medicine. NCT04784429 (mid enrollment · wide site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.